Jordi Casademont
Overview
Explore the profile of Jordi Casademont including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
77
Citations
972
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Barcelo M, Casademont J, Mascaro J, Gich I, Torres O
Age Ageing
. 2024 Jun;
53(6).
PMID: 38899445
Background: There are no studies focusing on treatment for osteoporosis in patients with exceptional longevity after suffering a hip fracture. Objective: To assess the advisability of initiating treatment for osteoporosis...
2.
Park H, Martinez-Martinez L, Lopez B, Castellvi I, Moya P, Codes-Mendez H, et al.
Front Immunol
. 2024 Mar;
15:1332924.
PMID: 38469314
Introduction: This was an ambispective cohort study evaluating the prognostic significance of lymphocytic foci and its lymphoid composition in minor salivary gland biopsy (MSGB) for short-term disease flare and severity...
3.
Sainz L, Riera P, Moya P, Bernal S, Casademont J, Diaz-Torne C, et al.
Arthritis Res Ther
. 2023 Nov;
25(1):226.
PMID: 38001504
Background: Sarilumab, an IL-6 receptor antagonist, is a first-line biologic disease-modifying anti-rheumatic drug for rheumatoid arthritis. The identification of genetic biomarkers as predictors of response to sarilumab could allow for...
4.
Barcelo M, Casademont J, Mascaro J, Gich I, Torres O
Aging Clin Exp Res
. 2023 Sep;
35(11):2483-2490.
PMID: 37688755
Background: Hip fractures are almost always the result of a fall. Causes and circumstances of falls may differ between frail and vigorous patients. Aim: To describe the circumstances of falls...
5.
6.
Hernandez-de Sosa N, Cardona Corrales R, Casademont J
Am J Case Rep
. 2023 Feb;
24:e938548.
PMID: 36841939
BACKGROUND Hereditary hemorrhagic telangiectasia (HHT) is a rare autosomal dominant genetic disease associated with arteriovenous malformations involving diverse organs. Neurological complications from brain abscesses (BA) secondary to pulmonary arteriovenous malformations...
7.
Sainz L, Riera P, Moya P, Bernal S, Casademont J, Diaz-Torne C, et al.
J Pers Med
. 2023 Jan;
13(1).
PMID: 36675722
Tocilizumab is a first-line biologic disease-modifying anti-rheumatic drug (bDMARD) that inhibits the interleukin-6 (IL-6) pathway by antagonizing the IL-6 receptor (IL-6R). Tocilizumab is widely used to treat rheumatoid arthritis (RA),...
8.
Role of Genetic Variants in Predicting Response to Tocilizumab in Patients with Rheumatoid Arthritis
Sainz L, Riera P, Moya P, Bernal S, Casademont J, Diaz-Torne C, et al.
Pharmaceutics
. 2022 Sep;
14(9).
PMID: 36145690
Rheumatoid arthritis (RA) is a prevalent autoimmune disease characterized by chronic arthritis that may lead to irreversible joint damage and significant disability. Patients with RA are commonly treated with Tocilizumab...
9.
Castellvi I, Castillo D, Corominas H, Mariscal A, Orozco S, Benito N, et al.
Front Med (Lausanne)
. 2022 Aug;
9:973918.
PMID: 36004366
Coronavirus disease 2019 (COVID-19) has rapidly expanded worldwide. Currently, there are no biomarkers to predict respiratory worsening in patients with mild to moderate COVID-19 pneumonia. Small studies explored the use...
10.
Franco-Leyva T, Torres O, Saez Prieto M, Boera-Carnicero G, Santos A, Clotet S, et al.
J Leukoc Biol
. 2022 Jun;
112(5):1183-1190.
PMID: 35748037
This study tested the hypothesis that a more senescent immune system would predict a worse outcome in older patients hospitalized for community-acquired pneumonia (CAP). CAP has long been responsible for...